Although POLD1 and POLE have recently been suggested as genes predisposing to hereditary EC, absolute risk for EC and even other cancer types is very uncertain, therefore the POLD1/POLE genetic testing of unselected EC patients should be restricted to the research setting (90). The gene discussed is POLE; the disease is cancer.